ANP infusion caused a vasodilatory effect, increased renal blood flow in patients with CKD and reduced the risk of con-trast-induced nephropathy after coronary angiography [161,162,163], but it could cause side effects such as bradycardia and hypotension [164]. Here, NPPA is linked to chronic kidney disease.